Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,682.29 -18.64 -0.69%
FTSE 100 6,331.48 -42.73 -0.67%
DAX 8,175.60 -53.91 -0.66%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Fund Type: Unit Trust
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

AXA Framlington Biotech Fund

+ Add to Watchlist

FRABIOZ:LN

147.70 GBp 0.60 0.40%

As of 00:59:30 ET on 06/18/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for AXA Framlington Biotech Fund (FRABIOZ)

Year To Date: - 3-Month: - 3-Year: - 52-Week Range: 147.70 - 148.30
1-Month: - 1-Year: - 5-Year: - Beta vs NBI: -

Mutual Fund Chart for FRABIOZ

No chart data available.
  • FRABIOZ:LN 147.70
  • 1M
  • 1Y
Interactive FRABIOZ Chart

Previous Close

Fund Profile & Information for FRABIOZ

AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.

Inception Date: 04-16-2012 Telephone: 44-207-374-4100
Managers: LINDEN THOMSON / GEMMA GAME
Web Site: www.axaframlington.com

Fundamentals for FRABIOZ

NAV (on 2013-06-18) 147.70
Assets (M) (on 2013-03-28) 127.99
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment 5,000.00

Dividends for FRABIOZ

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for FRABIOZ

Front Load 0.00
Back Load -
Current Mgmt Fee 0.75
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for FRABIOZ

Filing Date: 02/28/2013
Name Position Value % of Total
Gilead Sciences Inc 376,414 10,627,259 9.364%
Celgene Corp 137,913 9,171,809 8.082%
Amgen Inc 139,201 8,340,242 7.349%
Regeneron Pharmaceuticals Inc 73,116 7,931,751 6.989%
Alexion Pharmaceuticals Inc 113,472 6,459,573 5.692%
Vertex Pharmaceuticals Inc 150,158 4,642,677 4.091%
Biogen Idec Inc 41,584 4,545,595 4.005%
Onyx Pharmaceuticals Inc 75,395 3,839,853 3.383%
Illumina Inc 99,308 3,204,476 2.824%
Incyte Corp Ltd 203,599 2,896,209 2.552%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil